253 related articles for article (PubMed ID: 30671064)
1. Loss of JAK1 Drives Innate Immune Deficiency.
Witalisz-Siepracka A; Klein K; Prinz D; Leidenfrost N; Schabbauer G; Dohnal A; Sexl V
Front Immunol; 2018; 9():3108. PubMed ID: 30671064
[TBL] [Abstract][Full Text] [Related]
2. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
3. Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.
Losdyck E; Hornakova T; Springuel L; Degryse S; Gielen O; Cools J; Constantinescu SN; Flex E; Tartaglia M; Renauld JC; Knoops L
J Biol Chem; 2015 Nov; 290(48):29022-34. PubMed ID: 26446793
[TBL] [Abstract][Full Text] [Related]
4. Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.
Xu LJ; Ma Q; Zhu J; Li J; Xue BX; Gao J; Sun CY; Zang YC; Zhou YB; Yang DR; Shan YX
Mol Med Rep; 2018 Jun; 17(6):8111-8120. PubMed ID: 29693186
[TBL] [Abstract][Full Text] [Related]
5. Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade.
Curran SA; Shyer JA; St Angelo ET; Talbot LR; Sharma S; Chung DJ; Heller G; Hsu KC; Betts BC; Young JW
Cancer Immunol Res; 2017 Jan; 5(1):52-60. PubMed ID: 27923824
[TBL] [Abstract][Full Text] [Related]
6. ICOS deficiency hampers the homeostasis, development and function of NK cells.
Montes-Casado M; Ojeda G; Aragoneses-Fenoll L; López D; de Andrés B; Gaspar ML; Dianzani U; Rojo JM; Portolés P
PLoS One; 2019; 14(7):e0219449. PubMed ID: 31283790
[TBL] [Abstract][Full Text] [Related]
7. Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling.
Rochman Y; Kashyap M; Robinson GW; Sakamoto K; Gomez-Rodriguez J; Wagner KU; Leonard WJ
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19455-60. PubMed ID: 20974963
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells.
Bellucci R; Nguyen HN; Martin A; Heinrichs S; Schinzel AC; Hahn WC; Ritz J
J Clin Invest; 2012 Jul; 122(7):2369-83. PubMed ID: 22684105
[TBL] [Abstract][Full Text] [Related]
9. Janus kinase JAK1 maintains the ovarian reserve of primordial follicles in the mouse ovary.
Sutherland JM; Frost ER; Ford EA; Peters AE; Reed NL; Seldon AN; Mihalas BP; Russel DL; Dunning KR; McLaughlin EA
Mol Hum Reprod; 2018 Nov; 24(11):533-542. PubMed ID: 30247637
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severity.
Liu PC; Caulder E; Li J; Waeltz P; Margulis A; Wynn R; Becker-Pasha M; Li Y; Crowgey E; Hollis G; Haley P; Sparks RB; Combs AP; Rodgers JD; Burn TC; Vaddi K; Fridman JS
Clin Cancer Res; 2009 Nov; 15(22):6891-900. PubMed ID: 19887489
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of Cytokine Signaling 2 Negatively Regulates NK Cell Differentiation by Inhibiting JAK2 Activity.
Kim WS; Kim MJ; Kim DO; Byun JE; Huy H; Song HY; Park YJ; Kim TD; Yoon SR; Choi EJ; Jung H; Choi I
Sci Rep; 2017 Apr; 7():46153. PubMed ID: 28383049
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of three JAK-STAT pathway genes in feather follicle development during chicken embryogenesis.
Tao Y; Zhou X; Liu Z; Zhang X; Nie Y; Zheng X; Li S; Hu X; Yang G; Zhao Q; Mou C
Gene Expr Patterns; 2020 Jan; 35():119078. PubMed ID: 31759166
[TBL] [Abstract][Full Text] [Related]
13. Monocytes control natural killer cell differentiation to effector phenotypes.
Soderquest K; Powell N; Luci C; van Rooijen N; Hidalgo A; Geissmann F; Walzer T; Lord GM; Martín-Fontecha A
Blood; 2011 Apr; 117(17):4511-8. PubMed ID: 21389319
[TBL] [Abstract][Full Text] [Related]
14. NK Cell-Specific CDK8 Deletion Enhances Antitumor Responses.
Witalisz-Siepracka A; Gotthardt D; Prchal-Murphy M; Didara Z; Menzl I; Prinz D; Edlinger L; Putz EM; Sexl V
Cancer Immunol Res; 2018 Apr; 6(4):458-466. PubMed ID: 29386186
[TBL] [Abstract][Full Text] [Related]
15. The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3.
Lee SM; Yoon KB; Lee HJ; Kim J; Chung YK; Cho WJ; Mukai C; Choi S; Kang KW; Han SY; Ko H; Kim YC
Bioorg Med Chem; 2016 Nov; 24(21):5036-5046. PubMed ID: 27555284
[TBL] [Abstract][Full Text] [Related]
16. JAK1/2 inhibition impairs the development and function of inflammatory dendritic epidermal cells in atopic dermatitis.
Klaeschen AS; Nümm TJ; Herrmann N; Leib N; Maintz L; Sakai T; Wenzel J; Bieber T
J Allergy Clin Immunol; 2021 Jun; 147(6):2202-2212.e8. PubMed ID: 33338537
[TBL] [Abstract][Full Text] [Related]
17. Role of JAK1, JAK2, and JAK3 in Functional Stimulation of Mesenchymal Precursor Cells by Alkaloid Songorine.
Zyuz'kov GN; Udut EV; Miroshnichenko LA; Simanina EV; Polyakova TY; Stavrova LA; Udut VV; Minakova MY; Dygai AM; Chaikovskii AV; Agafonov VI; Zhdanov VV
Bull Exp Biol Med; 2017 Aug; 163(4):443-446. PubMed ID: 28853089
[TBL] [Abstract][Full Text] [Related]
18. A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro.
Murakami K; Kobayashi Y; Uehara S; Suzuki T; Koide M; Yamashita T; Nakamura M; Takahashi N; Kato H; Udagawa N; Nakamura Y
PLoS One; 2017; 12(7):e0181126. PubMed ID: 28708884
[TBL] [Abstract][Full Text] [Related]
19. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.
Kirken RA; Rui H; Malabarba MG; Howard OM; Kawamura M; O'Shea JJ; Farrar WL
Cytokine; 1995 Oct; 7(7):689-700. PubMed ID: 8580378
[TBL] [Abstract][Full Text] [Related]
20. Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation.
Liu KD; Gaffen SL; Goldsmith MA; Greene WC
Curr Biol; 1997 Nov; 7(11):817-26. PubMed ID: 9382798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]